The results of this study will lead to an improved insight in the lifecycle of these cells and our results will be of importance for more insight in chronic inflammatory diseases. For example, it will improve our ability to interpret the results…
ID
Source
Brief title
Condition
- Other condition
- Allergic conditions
Synonym
Health condition
fundamentele kennis mbt normale afweer
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Granulocyte and monocyte post-mitotic pool transit times and lifespans in
normal healthy volunteers
Secondary outcome
None
Background summary
Remarkably little is known about the lifecycle of the cells of the innate
immune system: monocytes, neutrophils, eosinophils and basophils. Knowledge
about this lifecycle is important for fundamental insights in the immune system
and also for the understanding of pathologies of inflammatory diseases. An
important difficulty is the development of new medications is is the lack of
knowledge on the basal characteristics of the cells that cause chronic
inflammation: how fast they are produced, how long they remain in the blood and
tissues and where they are cleared. Little is described in literature regarding
these topics. In the 60's and 70's studies were performed on the lifespans of
innate immune cells, but with inadequate techniques. These data probably
underestimate the lifespans of these cells, but they are still mentioned in
modern tekst books.
Study objective
The results of this study will lead to an improved insight in the lifecycle of
these cells and our results will be of importance for more insight in chronic
inflammatory diseases. For example, it will improve our ability to interpret
the results from previous and future intervention studies that block survival
and production of leukocytes.
Study design
On day one the volunteers will go to the clinic on an empty stomach.
First we will withdraw 20ml of blood for baseline measurements of glucose
levels and DNA deuterium enrichment.
After that, the volunteers will be orally administered 1g of deuterated glucose
per kilogram bodyweight in 12 doses over a period of 6 hours. Also, after 1, 3
and 6 hours after the first administration we will withdraw two drops of blood
by skinprick to determine the amount of deuterated glucose in the blood of the
volunteer.
During this day, the volunteer will receive low-carb breakfast and lunch.
At 5 more timepoints, the volunteer will come to the clinic to donate 20ml of
blood. The exact days after intake of glucose differ for each volunteer but
will not be in weekends or more than two days in a row. (A clear scheme of the
withdrawals can be found in the "onderzoeksprotocol", paragraph 3.2.)
From the collected blood DNA will be isolated and white blood cell populations
will be separated using high performance FACS sorting. DNA from these cells
will be isolated and analysed for deuterium enrichment using a combination of
gas chromatography and mass-spectometry.
These data will be fed to a mathematical model, which can calculate the
half-lives of the cells.
Study burden and risks
Risks:
The glucose used is considered safe, so risks are negligible
Burden:
Subject will pay five visits to the clinic for blood withdrawl. Each visit,
20ml of blood will be withdrawn, which can be easily missed by adults.
Besides, subjects will spend one day in hospital for one blood withdrawal and
the intake of 1g/kg bodyweight of glucose
Taken together, we think that the risks vor volunteers are minimal and the
burden is low.
Heidelberglaan 100
3584 CX Utrecht
NL
Heidelberglaan 100
3584 CX Utrecht
NL
Listed location countries
Age
Inclusion criteria
18-40 years
Exclusion criteria
• Any infection (eg. HIV, Hepatitis, STDs)
• Smoking
• Asthma or COPD
• Hay fever or allergies
• Auto-immune diseases
• Use of medication, excluding: anticonceptives and pain killers (if used less than once a week)
• exuberant alcohol consumption (for males > 36 glasses per week, for females >24 glasses per week)
• Drug use
• History of cancer
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL31552.041.10 |